• Fighting for Patient Access, Affordability, and Transparency in Health Care
Patients Rising Now
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Select Page
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Episode 37: How PBMs Profit at Your Expense

Episode 37: How PBMs Profit at Your Expense

Nov 7, 2020 | Featured, Pharmacy Benefit Managers

On this episode of the podcast, Terry and Bob discuss how pharmacy benefit managers (PBMs), middlemen between drug manufacturers and insurers, profit at patients’ expense. PBMs collect hundreds of billions of dollars worth of rebates each year from drug...
Episode 19: Prescription Price Transparency

Episode 19: Prescription Price Transparency

Jul 3, 2020 | Featured, Pharmacy Benefit Managers, Podcast

In this week’s episode of the Patients Rising Podcast, Terry and Bob discuss the role of Pharmacy Benefit Managers (PBMs) in raising the price and reducing the supply of medications.  PBMs are middlemen between drug manufacturers and insurers. They drive up drug...
This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

Jul 23, 2019 | Drug Costs, News, Pharmacy Benefit Managers

As the year began, patients seeking relief from high out-of-pocket health care costs had reason to be optimistic. A proposed rule introduced by the Department of Health and Human Services would have stopped pharmacy benefit managers and insurance companies from...

Categories

  • Actions
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • QALY
  • State Issues
  • Step Therapy
  • Uncategorized
  • Value Frameworks

Tags

340B Biden Administration Cancer chemo drugs cms Copay Accumulators copay assistance deferred action DPC drug costs drug discount programs Drug Importation Drug Manufacturing Drug Pricing drug rebate Elizabeth Warren fail first Health Insurance hospital bills HR 3708 hsa ICER immigration Imported Drugs Insurance design Joe Biden Medicaid medicare Part B medicare part D Nonmedical Switching open enrollment out of Out of Pocket Costs Patient Access Patients Assitance PBM pharmacy pharmacy benefit managers Preexisting Conditions Price Transparency Prior Authorization QALY Step Therapy transparency Value Framework

Recent Posts

  • New Government, Revised Rules? Seniors and Prescription Drug Cost-Sharing
  • S2 | E2: Mystery Hospital Costs 
  • S2 | E1: Will Democrats Help or Hurt Patients?
  • Episode 45: Pro-Patient Agenda Revealed
  • Episode 44: Patients Hurt by Most Favored Nation Rule

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.

Patients Rising Now

11710 Plaza America Drive
Suite 200
Reston, VA 20109
  • Privacy Policy
  • Sponsor Opportunities
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now